| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/09/2009 | US20090176826 Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
| 07/09/2009 | US20090176823 Secondary Amines as Renin Inhibitors |
| 07/09/2009 | US20090176812 3 -(4-Isopropoxyphenyl)-2-methyl-5-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-6-propylpyrimidin-4(3H) -one; for cardiovascular diseases, metabolic diseases and/or central nervous system diseases |
| 07/09/2009 | US20090176806 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer |
| 07/09/2009 | US20090176799 Phosphodiesterase 4 inhibitors |
| 07/09/2009 | US20090176798 New compounds III |
| 07/09/2009 | US20090176775 Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use |
| 07/09/2009 | US20090176773 Non-Peptidic Inhibitors of AKAP/PKA Interaction |
| 07/09/2009 | US20090176772 Method of reversing left ventricular remodeling |
| 07/09/2009 | US20090176758 blood coagulation factor (trypsin-like serine protease enzymes) inhibitor; 1-(3-amino-1,2-benzisoxazol-5-yl)-5-{[5-(2-oxo-1-piperidinyl)-2,3-dihydro-1H-indol-1-yl]carbonyl}-1H-pyrazole-3-carboxamide; anticoagulant; cardiovascular thromboembolic disorder transient ischemic attack, stroke, atherosclerosis |
| 07/09/2009 | US20090176713 Co-Administration of an Agent Linked to an Internalization Peptide with an Anti-Inflammatory |
| 07/09/2009 | US20090176704 treating Type II diabetes, eating disorders, and insulin-resistance syndrome with exendin peptide analogs of given amino acid sequence |
| 07/09/2009 | US20090176695 Reagents and Methods for Smooth Muscle Therapies |
| 07/09/2009 | US20090176694 Reagents and Methods for Smooth Muscle Therapies |
| 07/09/2009 | US20090175960 Process for Producing Carbon Dioxide Solution, Production Apparatus, And Carbonated Water |
| 07/09/2009 | US20090175942 Solid Dosage Form of Olmesartan Medoxomil And Amlodipine |
| 07/09/2009 | US20090175924 Coated stent |
| 07/09/2009 | US20090175912 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system |
| 07/09/2009 | US20090175893 Albumin-Fused Anti-Angiogenesis Peptides |
| 07/09/2009 | US20090175878 Cerebral Vasospasm Inhibitor |
| 07/09/2009 | DE60019555C5 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit 2-oxy-benzoxazinonderivate for treatment of obesity |
| 07/09/2009 | CA2711043A1 Method of synthesis of bosentan, its polymorphic forms and its salts |
| 07/09/2009 | CA2710775A1 Formulation |
| 07/09/2009 | CA2710743A1 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use |
| 07/09/2009 | CA2710665A1 Treatment of heart disease using .beta.-blockers |
| 07/09/2009 | CA2710458A1 Imidazo [1,2-b] pyridazine compounds as modulators of liver x receptors |
| 07/09/2009 | CA2710452A1 Imidazo [1,2-a] pyridine compounds |
| 07/09/2009 | CA2710379A1 Compositions containing sesamin-class compound(s) and quercetin glycoside(s) |
| 07/08/2009 | EP2077271A1 Macrolide derivative |
| 07/08/2009 | EP2077267A1 Fused heterocyclic compound |
| 07/08/2009 | EP2077116A1 Use of interleukin-11 as therapeutic agent for heart disease |
| 07/08/2009 | EP2077110A1 Glutamine-containing composition for increasing blood flow |
| 07/08/2009 | EP2076517A1 Spiro benzazepines as vasopressin antagonists |
| 07/08/2009 | EP2076499A2 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators |
| 07/08/2009 | EP2076290A1 Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis |
| 07/08/2009 | EP2076255A2 Use of hypothermia inducing drugs |
| 07/08/2009 | EP1948661B1 Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as pde5 inhibitors |
| 07/08/2009 | EP1620116B1 Use of quinquina for the preparation of a medicament stimulating angiogenesis |
| 07/08/2009 | EP1539933A4 Methods of organ regeneration |
| 07/08/2009 | EP1495022B1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 07/08/2009 | EP1440962B1 Stabilized compositions of aqueous reduced coenzyme q solution |
| 07/08/2009 | EP1401808B1 Gpe analogs and peptidomimetics |
| 07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
| 07/08/2009 | CN101479238A Amine derivative having npyy5 receptor antagonist activity |
| 07/08/2009 | CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 07/08/2009 | CN101475524A Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation |
| 07/08/2009 | CN100509846C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/08/2009 | CN100509811C Azaindoles |
| 07/08/2009 | CN100509810C Substituted beta-carbolines |
| 07/08/2009 | CN100509805C 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 07/08/2009 | CN100509804C N-substituted piperidine derivatives as serotonin receptor agents |
| 07/08/2009 | CN100509794C Therapeutic heterocyclic compounds |
| 07/08/2009 | CN100509791C Compound and use of the compound as glycine transport inhibitors |
| 07/08/2009 | CN100509789C Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 07/08/2009 | CN100509783C Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 07/08/2009 | CN100509782C NK* antagonists |
| 07/08/2009 | CN100509773C Alpha -amino-n-hydroxy-acetamide derivatives |
| 07/08/2009 | CN100509758C Crystal of triterpene derivative |
| 07/08/2009 | CN100509061C 改进的螯合剂缀合物 Improved chelator conjugate |
| 07/08/2009 | CN100509058C Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 07/08/2009 | CN100509046C Beta-cyclodextrin and polyoxyethylenated castor oil for preparing injection liquid for restoring conscious ness and preparing method thereof |
| 07/08/2009 | CN100509008C Shutongfang for killing pain and preparation and use thereof |
| 07/08/2009 | CN100508978C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 07/08/2009 | CN100508975C Use of pyrazolopyridine compound |
| 07/08/2009 | CN100508962C The use of kauranes compounds in the preparation of medicament |
| 07/07/2009 | US7557222 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors Xa and VIIa for the treatment of thrombosis |
| 07/07/2009 | US7557106 inhibitors of FLT-3, Aurora-1, Aurora-2, and Aurora-3 protein kinases; leukemia; N-{4-[4-(5-Methyl-2H-pyrazol-3-ylmethyl)-6-(4-propyl-piperazin-1-yl)-pyrim- idin-2-ylsulfanyl]-phenyl}-propionamide |
| 07/07/2009 | US7557105 Proliferative disorders; cancer; 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide |
| 07/07/2009 | US7556926 Drug screening; diabetes, obesity, hyperlipemia, arteriosclerosis, hypertension, cardiovascular disorders |
| 07/07/2009 | US7556827 Implantable active ingredient depot comprising matrix of glyceryl-monooleate and at least one modifier molecule comprising 1,2-distearoyl-glycerophosphatidyl-ethanolamin-methyl-polyethylene glycol wherein matrix provides controlled release of active ingredient |
| 07/07/2009 | US7556824 Transdermal patch comprising hydralazine derivative antioxidant and isosorbide di- and/or mononitrate |
| 07/07/2009 | CA2490002C Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 07/07/2009 | CA2486101C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 07/07/2009 | CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 07/02/2009 | WO2009082014A1 Drug delivery system |
| 07/02/2009 | WO2009081991A1 Therapeutic agent for cerebral ischemic injury |
| 07/02/2009 | WO2009081958A1 Glycosylated glycopeptide antibiotic derivative |
| 07/02/2009 | WO2009081957A1 Pyripyropene derivative having acat2-inhibiting activity |
| 07/02/2009 | WO2009081892A1 Novel catechol derivative, pharmaceutical composition containing the same, and use of those |
| 07/02/2009 | WO2009081789A1 Sulfonyl substituted 6-membered ring derivative |
| 07/02/2009 | WO2009081564A1 DAPKs INHIBITOR |
| 07/02/2009 | WO2009081087A1 Crystalline polymorph of doxazosin mesylate (form iv) and process for preparation thereof |
| 07/02/2009 | WO2009080242A1 Substituted 4-aminopyrimidine-5-carboxylic acid and use thereof |
| 07/02/2009 | WO2009080198A1 Fused cynopryridines and the use thereof |
| 07/02/2009 | WO2009080197A1 Substituted pyrrolo[2, 3-b] and pyrazolo[3, 4-b] pyridines for use as adenosine receptor ligands |
| 07/02/2009 | WO2009079941A1 A method for preparing buflomedil |
| 07/02/2009 | WO2009079902A1 The preparation and use of a curcumin-zinc compound and its solid dispersion |
| 07/02/2009 | WO2009063364A3 Modulators of urotensin receptor and methods of use thereof |
| 07/02/2009 | WO2009061445A3 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction |
| 07/02/2009 | WO2009046832A3 Short peptides used in medicine |
| 07/02/2009 | WO2009036149A9 Methods for treatment of degenerative disease associated with apoptosis |
| 07/02/2009 | WO2009033762A3 Use of endothelin-3 as a therapeutic agent |
| 07/02/2009 | WO2009033739A3 Use of a peptide as a therapeutic agent |
| 07/02/2009 | WO2009033678A3 Use of a tuftsin as a therapeutic agent |
| 07/02/2009 | WO2009010925A3 Annelated azaheterocyclic amides containing a pyrimidine fragment and method for the production and use thereof |
| 07/02/2009 | WO2008155403A3 Use of leptin in the prevention of unhealthy food habits and cardiovascular diseases |
| 07/02/2009 | WO2008142198A3 A method for inhibiting or stimulating angiogenesis in an individual |
| 07/02/2009 | WO2008074001A8 Renin inhibitors for the prevention and treatment of hypertension in obese patients |
| 07/02/2009 | WO2007127377A3 Combinations comprising omega-3 fatty acid compounds for the treatment of cardiovascular disease |
| 07/02/2009 | US20090170941 Pharmaceutical Compounds |